CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 91,806 shares at an average $381.49 ($35,023,032)
- 4 Planned sale General Counsel sold 1,077 shares at $400.00 ($430,800)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 144 Insider Sale of Securities
- 4 Planned sale President and CEO sold 11,583 shares at an average $538.65 ($6,239,198)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale General Counsel sold 664 shares at $514.97 ($341,940)
- 144 Insider Sale of Securities
- 4 Grant or award Director acquired 647 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market sale President and CEO sold 2,500 shares at an average $547.30 ($1,368,253)
- 144 Insider Sale of Securities
Page 1 of 62 · 1,224 filings